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Background: The elevation of troponin (TnI) and creatine kinase-MB (CKMB) after revascularization procedures may not be able to identify the 
presence of myocardial necrosis. Moreover, the presence of a biomarker early release peak, indicating nonlethal transient lesion, can help in the 
diagnosis of myocardial infarction associated with the procedure. Cardiac magnetic resonance (CMR) is the gold standard in the identification of 
small areas of myocardial necrosis by late gadolinium enhancement (LGE). Our objective was to evaluate the amount and pattern of release of 
biomarkers after coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) compared with the area of new LGE on CMR. 
methods: Patients with indication for coronary revascularization were included. Measurements of high-sensitivity TnI and CK-MB were obtained 
before and after the procedures, every 6 hours until 48 hours after PCI, and up to 72 hours after CABG. We evaluated the area under the curve 
(AUC) and peak release of biomarkers and stratified before and 24 hours after the procedure. CMR was performed before and after procedures with 
quantification of necrosis by LGE. 
results: From 150 patients who completed the study, 60 (40%) underwent CABG with cardiopulmonary bypass (CPB), 44 (29.3%) without CPB, 
and 46 (30.7%) underwent PCI. 130 (86.7%) exhibited release of cardiac biomarkers consistent with myocardial injury, however only 32 (21.3%) 
had new LGE on CMR. The AUC and peak release of TnI showed a moderate correlation with the mass of new myocardial LGE on CMR (AUC: r = 0.46, 
P < 0.0001; TnI peak: r = 0.45, P < 0.0001), as well as the AUC and peak release of CKMB (AUC: r = 0.33, P < 0.0001; CK-MB peak: r = 0.35, P 
<0.0001). Patients without new LGE on CMR had more frequently an early peak release of cardiac biomarkers when compared with those with new 
LGE: 63 (88.7%) vs. 8 (11.3%), P = 0.004. 
Conclusion: The elevation of cardiac biomarkers after coronary revascularization procedures had a low diagnostic power for the detection of new 
myocardial areas of infarction identified by LGE on CMR. The early release of biomarkers may be useful to identify patients who will not present 
infarction related to the procedure.
